HFE H63D Mutation and Breast Cancer in Turkish Women
Author Information
Author(s): Gunel-Ozcan Aysen, Alyılmaz-Bekmez Sibel, Guler Emine Nilufer, Guc Dicle
Primary Institution: Hacettepe University Oncology Institute
Hypothesis
Is there a significant association between HFE H63D mutation frequency and breast cancer in Turkish women?
Conclusion
HFE H63D mutation frequencies were found to be higher in breast cancer patients compared to healthy controls.
Supporting Evidence
- 39 breast cancer patients had the H63D mutation, all of whom were heterozygous.
- H63D allele frequency was 22.2% in breast cancer patients compared to 14% in healthy controls.
- Statistical analysis showed a significant difference in H63D mutation prevalence between the two groups.
Takeaway
This study found that a specific gene mutation, H63D, is more common in women with breast cancer than in healthy women.
Methodology
DNA samples were analyzed using PCR-RFLP to detect HFE gene mutations.
Potential Biases
Potential confounding factors were not fully controlled for, such as dietary or medication history.
Limitations
The study had a small sample size and could not assess the effect of H63D on serum iron parameters.
Participant Demographics
The breast cancer patients had a mean age of 41 years, while the control group had a mean age of 33 years.
Statistical Information
P-Value
0.02
Confidence Interval
95% CI = 1.12 to 3.75
Statistical Significance
p=0.02
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website